BOSTON--(BUSINESS WIRE)--Ibex Medical Analytics (Ibex), the leader in artificial intelligence (AI)-powered cancer diagnostics, today announced the publication of a clinical study evaluating Ibex ...
Please provide your email address to receive an email when new articles are posted on . AI improved accuracy of HER2 breast cancers with reference scores. AI decreased misclassification of HER2-low ...
AI assistance reduced the misclassification of HER2-low and HER2-ultralow breast cancers as HER2-null by 24%. An online training platform integrated with artificial intelligence (AI) can help ...
CHICAGO -- Artificial intelligence (AI) assistance appeared to enhance pathologists' accuracy in identifying HER2-low or -ultralow expression in breast cancer tissue, a global study showed, which ...
Trastuzumab deruxtecan improves survival in HER2-low and HER2-ultralow breast cancer, necessitating accurate patient classification. AI significantly enhances pathologists' accuracy in HER2 ...
Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. Over the next 12 months, tens of thousands of women across ...
A study from PreciseDx showed that its artificial-intelligence-guided pathology test could help predict a patient’s chances of their breast cancer returning on par with a leading genomic approach.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results